Please assess the completion status of the following clinical trial:

Trial Title: Dose Finding Study for Retarded Phosphatidylcholine in Pancolitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* chronic active ulcerative pancolitis~* course more than 4 months~* clinical index rachmilewitz 7 or more~* endoskopic index 7 or more~Exclusion Criteria:~* steroids in the last 4 weeks~* immunosuppressants in the last 4 weeks~* use of topical klymsa~* pregnancy~* fulminant course~* infectious colitis

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).